GlaxoSmithKline Pharmaceuticals Limited — Others, 31-03-2025: Copy of Newspaper Publication

The company has announced a board meeting to discuss the financial results for the quarter and half-year. The outcomes of this meeting could provide insights into the company's performance and future strategies, potentially influencing investor sentiment. Investors may view this as a pivotal opportunity to assess the company's financial health and strategic direction. The meeting's results could lead to a positive outlook or highlight potential risks, making it essential for shareholders to stay informed on subsequent developments.